Paraquat Poisoning
Introduction
 Paraquat is a rapidly acting, non selective
herbicide ; inexpensive
 Dermal /spray exposure(inhalation)-limited
localised injury
 Ingestion-high case fatality rate
 Diquat is a related herbicide-similar mechanism,
clinical features, treatment
 Coformulated with an antiemetic/alginate to reduce
absorption
Pharmacology and cellullar
toxocology
 Chemically- bi pyridyl compounds
 Absorption..concentrated inside cells..redox
cycling( repetitive enzyme mediated cycling
between paraquat and its radicals)
 Byproduct- superoxide radical
 Redox cycling –consumes NADPH(antioxidant)
 Oxidative stress-cellullar damage
 Secondary inflammatory response
 Multiorgan failure-organs with high blood
flow,oxygen tension and energy requirements-
lungs/heart/kidneys/liver
Kinetics
 Highly polar and corrosive
 Ingestion ..rapid absorption..rapid distribution
 Max tissue levels..6hrs
 Active uptake by cell membrane transporters(eg:
spermidine/putrescine)
 High conc: in liver, lungs, kidney,muscle
 No significant phase 1/phase 2 biotransformation
 Elimination –kidneys
 Minor-most ingested will appear in urine by 24 hrs
 Severe-kidney function impaired..elimination
delayed..elimination half life can exceed 100 hrs
Clinical features:
History
 Formulation , strength and dose are important-
>30ml of 20% paraquat can be lethal.
 Kidney disease and age>50yrs- bad prognosis
 Time of ingestion
 Painful mouth, difficulty in swallowing, nausea,
vomiting , abdominal pain
 Burning skin sensation
 Respiratory complaints-systemic poisoning
Physical examination and basic
monitoring
 Mouth,pharynx- necrosis, inflammation, ulceration-
maybe delayed to upto 12 hours, peak severity in
some days later
 Dehydration(vomiting)
 Monitor respiratory rate, pulse oximetry- O2 only if
SpO2<90%
 Heart rate, BP- progressive refractory hypotension
 Chest-dyspnoeic, tachypnoeic, crackles
(alveolitis).subcutaneous emphysema-
mediastinitis
 Abdominal pain, diffuse tenderness
 Topical contact- corneal ulceration, non specific
dermatitis
Lab evaluation
 General testing:
 Blood tests- on admission, every 6 to 12th hourly for
first 48 hours, then based on clinical severity-
vomiting, diarrhea, kidney injury.
 If prognosis is poor - palliative measures
 Serum electrolytes- may be altered due to
vomiting, diarrhea, acute kidney injury and multi
organ dysfunction.
 Renal function-
◦ AKI suggests significant poisoning-acute tubular
necrosis/volume depletion-increased mortality
◦ Serum creatinine-rate of increase correlates with survival -
<0.034mg% per hr over 5 hrs(survival); >0.049mg% per hr
over 6hrs(death)
◦ Serum cystatin C- >0.009mg/L per hr over 6 hrs (death)
 Blood gas-
◦ Alkalemia-vomiting, early in the course
◦ Acidemia- respiratory acidosis( alveolitis,
pneumonitis) and metabolic acidosis( diarrhea,
AKI, mitochondrial toxicity, hypotension)
 Respiratory index >1.5(death)
 Arterial Lactate- MODS, hypotension, ARDS.
Lactate concentration >40mg%-fatal outcome-
helps determine prognosis
 Chest radiograph- for assessing acute lung injury(
hypoxia/hyperventilation/crackles)-direct effect of
paraquat(bilateral) / aspiration( focal-mostly right
lung).
 early phase(1-2 weeks)-diffuse alveolar
infiltrates-ARDS
 late phase-reticulointerstitial infiltrates-
progressive fibrosis
 Toxicology screen- for patients in altered mental
status-usually not caused by paraquat- but by
acetaminophen exposure etc
 Specific testing:
 Urine paraquat- inexpensive; based on color
change after addition of dithionite soln to urine-
positive within 6 hrs after large ingestion,remains
positive for several days.
 Positive test-40% mortality. Negative- 100 %
survival
 Methods : 100mg sod.dithionite to 10ml of 2M
sodium hydroxide- 200ul of this to 2ml urine-
blue(paraquat), green(diquat)- darker the color,
more the concentration
 Serum paraquat- nomograms –correlate serum
paraquat concentration with mortality risk
 The proudfoot nomogram, best cut off for the
Severity in Paraquat Poisoning(Sipp)
 Sipp score-paraquat concentration(mg/dl) x time
since poisoning(hrs)..score <10 survival is likely.
 Challenges –imprecise time of exposure, paraquat
assay within a relevant time frame.
 Qualitative serum paraquat- in patients with
positive urinary dithionite test
 soln prepared as before.. But added to 2ml of
plasma instead of urine- equivocal color change-
50% mortality, definitive color change-100 %
mortality
 Topical exposure-no need of investigations.
 If in doubt- urinary dithionite at 6 and 12 hrs for
reassurance.
Diagnosis
 h/o ingestion/exposure
 Physical examination-oropharyngeal burns etc
 Subsequent development of: AKI, metabolic
acidosis, or ARDS
 Lab confirmation-urine dithionite test
Differential diagnosis
 No other pesticide makes such severe oral burns
 Most corrosives do not cause acute systemic
toxicity
 Previously was mistaken for HIV related infections-
oral candidiasis/Pneumocystis jiroveci pneumonia
Management -overview
 Determined on an individual basis based on
amount ingested, time elapsed since exposure
 None of the current treatments are effective in
severe poisoning
 Symptoms/signs manifest in 6 to 12 hrs- need
monitoring atleast for this duration.
 Negative urinary dithionite test at 6 hrs- minimal
exposure.
 GI decontamination to limit systemic exposure
 Hemoperfusion followed by
hemodiafiltration/repeated hemoperfusion may be
beneficial if commenced within 4 hrs of exposure
 Antedotes- antiflammatory and antioxidant
therapies- limited data to support efficacy.
 For severe poisoning- better approach may be
palliative care.
 Titrated fentanyl/morphine.
Initial resuscitation
 Follows standard guidelines??
 O2 should not be administered unless SpO2 <90%.
 Hydration -2 to 3 L of isotonic crystalloids or more
 Continuous pulse oximetry
 For severe systemic illness- active management
may be futile.but decision can be taken based on
history/prognostic tests/clinical signs
 Gastro intestinal decontamination:
◦ If presented within 2 hrs of exposure: Activated
charcoal 1g/kg in water, max dose 50g ; per oral or via NG
tube
◦ Gastric lavage and forced emesis are contraindicated- caustic
injury
◦ NG tube aspiration prior to charcoal administration
 Topical/inhalational exposure:
◦ Wash with soap and water for 15 mins.
◦ Staff should use universal precautions
◦ Ocular exposure- standard treatment for corrosive exposure??-
rinsing for 30 mins then standard protocol??
 Monitoring: pulse oximetry.
Specific treatments and
antidotal therapy:
 Indications for extracorporeal therapies:
◦ Hemoperfusion for 4 hrs if initiated within 4 hrs of ingestion.
◦ Haemodialysis/hemofiltration may be used –paraquat has
less protein binding.??; can also be used in AKI as renal
replacement therapy.
◦ Rebound in plasma paraquat following hemoperfusion can
be minimised with continuous extracorporeal technique.
 Antinflammatory and immunosuppressive therapy:
 Cyclophosphamide+glucocorticoid- not validated
by studies
 Antioxidant therapy-acetylcysteine, sodium
salicylate, deferoxamine, vitamin C, vitamin E.
Ongoing management
 Avoid O2 unless hypoxic
 Correct electrolyte abnormalities
 Monitor blood lactate concentrations, renal function
 Acute hepatic injury/pancreatitis- do not influence
prognosis
 The likely outcome is generally apparent within a
day or two:
◦ Either critically ill with severe poisoning
◦ Mild to moderate poisoning but adequately compensated
without intervention
◦ Asymptomatic
 Renal failure resolves in weeks
 Lung injury becomes progressively more severe for
several weeks.
◦ Lung transplant ineffective- paraquat injures the allograft
 Diquat- may be associated with MODS and rapid
death similar to paraquat.
◦ But survivors are most likely to recover and not experience
delayed or progressive respiratory failure
 Thankyou

Paraquat poisoning

  • 1.
  • 2.
    Introduction  Paraquat isa rapidly acting, non selective herbicide ; inexpensive  Dermal /spray exposure(inhalation)-limited localised injury  Ingestion-high case fatality rate  Diquat is a related herbicide-similar mechanism, clinical features, treatment  Coformulated with an antiemetic/alginate to reduce absorption
  • 3.
    Pharmacology and cellullar toxocology Chemically- bi pyridyl compounds  Absorption..concentrated inside cells..redox cycling( repetitive enzyme mediated cycling between paraquat and its radicals)  Byproduct- superoxide radical  Redox cycling –consumes NADPH(antioxidant)  Oxidative stress-cellullar damage  Secondary inflammatory response  Multiorgan failure-organs with high blood flow,oxygen tension and energy requirements- lungs/heart/kidneys/liver
  • 4.
    Kinetics  Highly polarand corrosive  Ingestion ..rapid absorption..rapid distribution  Max tissue levels..6hrs  Active uptake by cell membrane transporters(eg: spermidine/putrescine)  High conc: in liver, lungs, kidney,muscle  No significant phase 1/phase 2 biotransformation  Elimination –kidneys  Minor-most ingested will appear in urine by 24 hrs  Severe-kidney function impaired..elimination delayed..elimination half life can exceed 100 hrs
  • 5.
    Clinical features: History  Formulation, strength and dose are important- >30ml of 20% paraquat can be lethal.  Kidney disease and age>50yrs- bad prognosis  Time of ingestion  Painful mouth, difficulty in swallowing, nausea, vomiting , abdominal pain  Burning skin sensation  Respiratory complaints-systemic poisoning
  • 6.
    Physical examination andbasic monitoring  Mouth,pharynx- necrosis, inflammation, ulceration- maybe delayed to upto 12 hours, peak severity in some days later  Dehydration(vomiting)  Monitor respiratory rate, pulse oximetry- O2 only if SpO2<90%  Heart rate, BP- progressive refractory hypotension  Chest-dyspnoeic, tachypnoeic, crackles (alveolitis).subcutaneous emphysema- mediastinitis  Abdominal pain, diffuse tenderness  Topical contact- corneal ulceration, non specific dermatitis
  • 7.
    Lab evaluation  Generaltesting:  Blood tests- on admission, every 6 to 12th hourly for first 48 hours, then based on clinical severity- vomiting, diarrhea, kidney injury.  If prognosis is poor - palliative measures
  • 8.
     Serum electrolytes-may be altered due to vomiting, diarrhea, acute kidney injury and multi organ dysfunction.  Renal function- ◦ AKI suggests significant poisoning-acute tubular necrosis/volume depletion-increased mortality ◦ Serum creatinine-rate of increase correlates with survival - <0.034mg% per hr over 5 hrs(survival); >0.049mg% per hr over 6hrs(death) ◦ Serum cystatin C- >0.009mg/L per hr over 6 hrs (death)
  • 9.
     Blood gas- ◦Alkalemia-vomiting, early in the course ◦ Acidemia- respiratory acidosis( alveolitis, pneumonitis) and metabolic acidosis( diarrhea, AKI, mitochondrial toxicity, hypotension)  Respiratory index >1.5(death)  Arterial Lactate- MODS, hypotension, ARDS. Lactate concentration >40mg%-fatal outcome- helps determine prognosis
  • 10.
     Chest radiograph-for assessing acute lung injury( hypoxia/hyperventilation/crackles)-direct effect of paraquat(bilateral) / aspiration( focal-mostly right lung).  early phase(1-2 weeks)-diffuse alveolar infiltrates-ARDS  late phase-reticulointerstitial infiltrates- progressive fibrosis  Toxicology screen- for patients in altered mental status-usually not caused by paraquat- but by acetaminophen exposure etc
  • 11.
     Specific testing: Urine paraquat- inexpensive; based on color change after addition of dithionite soln to urine- positive within 6 hrs after large ingestion,remains positive for several days.  Positive test-40% mortality. Negative- 100 % survival  Methods : 100mg sod.dithionite to 10ml of 2M sodium hydroxide- 200ul of this to 2ml urine- blue(paraquat), green(diquat)- darker the color, more the concentration
  • 12.
     Serum paraquat-nomograms –correlate serum paraquat concentration with mortality risk  The proudfoot nomogram, best cut off for the Severity in Paraquat Poisoning(Sipp)  Sipp score-paraquat concentration(mg/dl) x time since poisoning(hrs)..score <10 survival is likely.  Challenges –imprecise time of exposure, paraquat assay within a relevant time frame.
  • 13.
     Qualitative serumparaquat- in patients with positive urinary dithionite test  soln prepared as before.. But added to 2ml of plasma instead of urine- equivocal color change- 50% mortality, definitive color change-100 % mortality  Topical exposure-no need of investigations.  If in doubt- urinary dithionite at 6 and 12 hrs for reassurance.
  • 14.
    Diagnosis  h/o ingestion/exposure Physical examination-oropharyngeal burns etc  Subsequent development of: AKI, metabolic acidosis, or ARDS  Lab confirmation-urine dithionite test
  • 15.
    Differential diagnosis  Noother pesticide makes such severe oral burns  Most corrosives do not cause acute systemic toxicity  Previously was mistaken for HIV related infections- oral candidiasis/Pneumocystis jiroveci pneumonia
  • 16.
    Management -overview  Determinedon an individual basis based on amount ingested, time elapsed since exposure  None of the current treatments are effective in severe poisoning  Symptoms/signs manifest in 6 to 12 hrs- need monitoring atleast for this duration.  Negative urinary dithionite test at 6 hrs- minimal exposure.
  • 17.
     GI decontaminationto limit systemic exposure  Hemoperfusion followed by hemodiafiltration/repeated hemoperfusion may be beneficial if commenced within 4 hrs of exposure  Antedotes- antiflammatory and antioxidant therapies- limited data to support efficacy.  For severe poisoning- better approach may be palliative care.  Titrated fentanyl/morphine.
  • 18.
    Initial resuscitation  Followsstandard guidelines??  O2 should not be administered unless SpO2 <90%.  Hydration -2 to 3 L of isotonic crystalloids or more  Continuous pulse oximetry  For severe systemic illness- active management may be futile.but decision can be taken based on history/prognostic tests/clinical signs
  • 19.
     Gastro intestinaldecontamination: ◦ If presented within 2 hrs of exposure: Activated charcoal 1g/kg in water, max dose 50g ; per oral or via NG tube ◦ Gastric lavage and forced emesis are contraindicated- caustic injury ◦ NG tube aspiration prior to charcoal administration  Topical/inhalational exposure: ◦ Wash with soap and water for 15 mins. ◦ Staff should use universal precautions ◦ Ocular exposure- standard treatment for corrosive exposure??- rinsing for 30 mins then standard protocol??  Monitoring: pulse oximetry.
  • 20.
    Specific treatments and antidotaltherapy:  Indications for extracorporeal therapies: ◦ Hemoperfusion for 4 hrs if initiated within 4 hrs of ingestion. ◦ Haemodialysis/hemofiltration may be used –paraquat has less protein binding.??; can also be used in AKI as renal replacement therapy. ◦ Rebound in plasma paraquat following hemoperfusion can be minimised with continuous extracorporeal technique.
  • 21.
     Antinflammatory andimmunosuppressive therapy:  Cyclophosphamide+glucocorticoid- not validated by studies  Antioxidant therapy-acetylcysteine, sodium salicylate, deferoxamine, vitamin C, vitamin E.
  • 22.
    Ongoing management  AvoidO2 unless hypoxic  Correct electrolyte abnormalities  Monitor blood lactate concentrations, renal function  Acute hepatic injury/pancreatitis- do not influence prognosis  The likely outcome is generally apparent within a day or two: ◦ Either critically ill with severe poisoning ◦ Mild to moderate poisoning but adequately compensated without intervention ◦ Asymptomatic
  • 23.
     Renal failureresolves in weeks  Lung injury becomes progressively more severe for several weeks. ◦ Lung transplant ineffective- paraquat injures the allograft  Diquat- may be associated with MODS and rapid death similar to paraquat. ◦ But survivors are most likely to recover and not experience delayed or progressive respiratory failure
  • 24.